ED
UWTI

Exane Derivatives’s VelocityShares 3x Long Crude Oil ETN linked to the S&P GSCI Crude Oil Index ER due February 9, UWTI Stock Holding History

Exane Derivatives’s Portfolio UWTI Stock Details UWTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-59,214
Closed -$1.43M – 692
2016
Q3 		$1.43M Buy
59,214
+35,801
+153% +$817K 0.21% 80
2016
Q2 		$759K Sell
23,413
-14,996
-39% -$467K 0.13% 101
2016
Q1 		$818K Buy
+38,409
New +$819K 0.11% 103

Other funds holding UWTI

FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
FMP
Financial Management Professionals Austin, Texas $1.05B AUM 21.07% 1-Year Est. Return

Exane Derivatives's UWTI Position: Q4 2016 in Review

Exane Derivatives sold out of VelocityShares 3x Long Crude Oil ETN linked to the S&P GSCI Crude Oil Index ER due February 9, (UWTI) in Q4 2016, closing a stake of 59,214 shares — an estimated $1.43M sold.

Exane Derivatives first reported a position in UWTI in Q1 2016 and held it in 3 quarters. The position peaked at $1.43M in Q3 2016. 5 funds tracked by Wall St. Rank hold UWTI as of Q4 2016.

  • Exane Derivatives reported no remaining VelocityShares 3x Long Crude Oil ETN linked to the S&P GSCI Crude Oil Index ER due February 9, position as of Q4 2016 after selling out during the quarter.
  • Exane Derivatives sold 59,214 VelocityShares 3x Long Crude Oil ETN linked to the S&P GSCI Crude Oil Index ER due February 9, shares in Q4 2016, an estimated $1.43M.
  • Exane Derivatives first reported a position in VelocityShares 3x Long Crude Oil ETN linked to the S&P GSCI Crude Oil Index ER due February 9, in Q1 2016 and held it in 3 quarters.
  • Exane Derivatives's VelocityShares 3x Long Crude Oil ETN linked to the S&P GSCI Crude Oil Index ER due February 9, position peaked at $1.43M in Q3 2016.
  • 5 funds tracked by Wall St. Rank held VelocityShares 3x Long Crude Oil ETN linked to the S&P GSCI Crude Oil Index ER due February 9, as of Q4 2016.

Based on Exane Derivatives's 13F filing for Q4 2016, filed 27 Jan 2017.